Guggenheim Capital LLC Simulations Plus, Inc. Transaction History

Guggenheim Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$38.45 - $55.66 $286,490 - $414,722	-7,451 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$49.67 - $68.96 $10,877 - $15,102	-219 Reduced 2.86%	7,451 $409,000
Q1 2021 May 13, 2021	SELL	$60.06 - $89.52 $433,032 - $645,439	-7,210 Reduced 48.45%	7,670 $485,000
Q4 2020 Feb 16, 2021	BUY	$53.26 - $77.18 $599,175 - $868,275	11,250 Added 309.92%	14,880 $1.07 Million
Q3 2020 Nov 13, 2020	SELL	$57.51 - $75.36 $111,569 - $146,198	-1,940 Reduced 34.83%	3,630 $274,000
Q2 2020 Aug 14, 2020	BUY	$32.91 - $59.82 $183,308 - $333,197	5,570 New	5,570 $333,000

180

15.9M

3.9K

200

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $641M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.